Distinct chromosomal profiles in metastasizing and non-metastasizing colorectal carcinomas

16Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: The prognosis of colorectal cancer patients is to a considerable extent determined by the metastatic potency of the primary tumor. However, despite the fact that liver metastases are the leading cause of death for cancer patients, the molecular basis still remains poorly understood and independent prognostic markers have not been established. Materials and methods: Comparative genomic hybridization (CGH) was used to screen colorectal carcinomas without distant metastases (n=18) and carcinomas synchronously metastatic to the liver (n=18). We aimed to detect distinct chromosomal aberrations indicating a metastatic phenotype. Results and discussion: Metastatic tumors exhibited a significantly (P=0.03) higher ANCA value (13.8) if compared with non-metastatic cancers (10.0). Furthermore, we observed that losses of chromosomal regions 1p32-ter and 9q33-ter were present at much higher frequencies in metastatic than in non-metastatic cancers, respectively (P=0.02 and 0.04). Conclusion: These data indicate that metastatic tumors may be separated from non-metastatic colorectal cancers based on their genomic profile. © 2006 - IOS Press and the authors. All rights reserved.

Cite

CITATION STYLE

APA

Ghadimi, B. M., Grade, M., Mönkemeyer, C., Kulle, B., Gaedcke, J., Gunawan, B., … Becker, H. (2006). Distinct chromosomal profiles in metastasizing and non-metastasizing colorectal carcinomas. Cellular Oncology, 28(5–6), 273–281. https://doi.org/10.1155/2006/529190

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free